Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS

  • Read more about USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS
US Patent 5,814,667
Filed on 1997-03-11

ASSAYS FOR IDENTIFYING ANTIOXIDANT COMPOUNDS WHICH PROTECT AGAINST FREE RADICAL-INDUCED DNA LESIONS

  • Read more about ASSAYS FOR IDENTIFYING ANTIOXIDANT COMPOUNDS WHICH PROTECT AGAINST FREE RADICAL-INDUCED DNA LESIONS
US Patent 6,017,706
Filed on 1997-05-07

HUMAN PAPILLOMA VIRUS INHIBITION BY A HAIRPIN RIBOZYME

  • Read more about HUMAN PAPILLOMA VIRUS INHIBITION BY A HAIRPIN RIBOZYME
US Application 08/737,454
Filed on 1995-05-15

Anti-CD22 Chimeric Antigen Receptors

  • Read more about Anti-CD22 Chimeric Antigen Receptors
Patent Cooperation Treaty
PCT/US2012/061025
Filed on 2012-10-19

Mesothelium Antigen and Methods and Kits For Targeting It

  • Read more about Mesothelium Antigen and Methods and Kits For Targeting It
US Patent 6,083,502
Filed on 1998-01-12

IMPORTANCE OF THE ZINC FINGER OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE IN BINDING TO AND INHIBITION BY GUANOSINE QUARTER STRUCTURES

  • Read more about IMPORTANCE OF THE ZINC FINGER OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE IN BINDING TO AND INHIBITION BY GUANOSINE QUARTER STRUCTURES
US Patent 6,323,185
Filed on 1996-07-17

PEPTIDOMIMETIC INHIBITORS OF CATHEPSIN D AND PLASMEPSINS I AND II

  • Read more about PEPTIDOMIMETIC INHIBITORS OF CATHEPSIN D AND PLASMEPSINS I AND II
Patent Cooperation Treaty
PCT/US1997/002930
Filed on 1997-02-20

METHODS FOR PREDICTING THE EFFICACY OF A CHEMOTHERAPEUTIC REGIMEN FOR GASTROINTESTINAL CANCERS USING ANTIBODIES SPECIFIC FOR THYMIDYLATE...

  • Read more about METHODS FOR PREDICTING THE EFFICACY OF A CHEMOTHERAPEUTIC REGIMEN FOR GASTROINTESTINAL CANCERS USING ANTIBODIES SPECIFIC FOR THYMIDYLATE...
US Patent 5,998,151
Filed on 1996-11-27

Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines

  • Read more about Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines
Japan
2001-579837
Filed on 2001-04-28

2-ALKOXY ESTRADIOL ANALOGS: ANTIANGIOGENIC AND ANTICANCER AGENTS

  • Read more about 2-ALKOXY ESTRADIOL ANALOGS: ANTIANGIOGENIC AND ANTICANCER AGENTS
US Application 60/059,916
Filed on 1997-09-27

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1547
  • Page 1548
  • Page 1549
  • Page 1550
  • Page 1551
  • Page 1552
  • Page 1553
  • Page 1554
  • Page 1555
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health